TP53 status and gene amplification in human colorectal carcinomas

被引:6
作者
Soulié, P
Fourme, E
Hamelin, R
Asselain, B
Salmon, RJ
Dutrillaux, B
Muleris, M
机构
[1] Inst Curie, CNRS UMR147, F-75248 Paris 05, France
[2] Inst Curie, Unite Biostat, F-75248 Paris 05, France
[3] Inst Curie, Dept Surg, F-75248 Paris 05, France
[4] INSERM U434 CEPH, Paris, France
关键词
D O I
10.1016/S0165-4608(99)00073-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gene amplification is one of the characteristics of cancer cells. In vitro studies suggested that alterations of the TP53 gene might be responsible for gene amplification. We have examined the presence of TP53 mutations and looked for cytogenetic evidence of gene amplification in a series of 79 primary colorectal carcinomas. Of her parameters such as the pattern of cytogenetic alterations, microsatellite instability tumor site, and histological staging were of so considered. A multiparametric study supported by statistical analyses suggests the existence of two major path was of colorectal carcinogenesis. No relationships could be established between the presence of TP53 alterations and gene amplification. (C) 1999 Elsevier Science, Inc. All rights reserved.
引用
收藏
页码:118 / 122
页数:5
相关论文
共 50 条
[31]   The relationship between TP53 gene status and carboxylesterase 2 expression in human gastric cancer [J].
Kohira, Yoshinori ;
Lee, Hyeon-Cheol ;
Ishimine, Momoko ;
Orita, Hajime ;
Kobayashi, Toshiyuki ;
Sato, Koichi ;
Yokomizo, Takehiko ;
Fukunaga, Tetsu .
CANCER RESEARCH, 2019, 79 (13)
[32]   THE TP53 TUMOR SUPPRESSOR GENE IN COLORECTAL CARCINOMAS .2. RELATION TO DNA PLOIDY PATTERN AND CLINICOPATHOLOGICAL VARIABLES [J].
MELING, GI ;
LOTHE, RA ;
BORRESEN, AL ;
GRAUE, C ;
HAUGE, S ;
CLAUSEN, OPF ;
ROGNUM, TO .
BRITISH JOURNAL OF CANCER, 1993, 67 (01) :93-98
[33]   P53/Tp53 status in keratoacanthomas [J].
Joshi, S. ;
Schjolberg, A. ;
De Angelis, P. M. ;
Ekstrom, P. O. ;
Clausen, O. P. .
VIRCHOWS ARCHIV, 2015, 467 :S48-S48
[34]   Tp53/p53 status in keratoacanthomas [J].
Joshi, Sarita ;
Schjolberg, Aasa R. ;
Ekstrom, Per Olaf ;
De Angelis, Paula M. ;
Zucknick, Manuela ;
Andersen, Solveig Norheim ;
Clausen, Ole Petter F. .
JOURNAL OF CUTANEOUS PATHOLOGY, 2016, 43 (07) :571-578
[35]   TP53 Gene Status Affects Survival in Advanced Mycosis Fungoides [J].
Wooler, Gitte ;
Melchior, Linea ;
Ralfkiaer, Elisabeth ;
Gjerdrum, Lise Mette Rahbek ;
Gniadecki, Robert .
FRONTIERS IN MEDICINE, 2016, 3
[36]   Why are there hotspot mutations in the TP53 gene in human cancers? [J].
Baugh, Evan H. ;
Ke, Hua ;
Levine, Arnold J. ;
Bonneau, Richard A. ;
Chan, Chang S. .
CELL DEATH AND DIFFERENTIATION, 2018, 25 (01) :154-160
[37]   Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathway [J].
Saba, Karim H. ;
Difilippo, Valeria ;
Kovac, Michal ;
Cornmark, Louise ;
Magnusson, Linda ;
Nilsson, Jenny ;
van den Bos, Hilda ;
Spierings, Diana C. J. ;
Bidgoli, Mahtab ;
Jonson, Tord ;
Sumathi, Vaiyapuri P. ;
Brosjoe, Otte ;
Staaf, Johan ;
Foijer, Floris ;
Styring, Emelie ;
Nathrath, Michaela ;
Baumhoer, Daniel ;
Nord, Karolin H. .
JOURNAL OF PATHOLOGY, 2024, 262 (02) :147-160
[38]   MDM2 gene amplification is correlated to tumor progression but not to the presence of SNP309 or TP53 mutational status in primary colorectal cancers [J].
Forslund, Ann ;
Zeng, Zhaoshi ;
Qin, Li-Xuan ;
Rosenberg, Shoshana ;
Ndubuisi, MacKevin ;
Pincas, Hanna ;
Gerald, William ;
Notterman, Daniel A. ;
Barany, Francis ;
Paty, Philip B. .
MOLECULAR CANCER RESEARCH, 2008, 6 (02) :205-211
[39]   Why are there hotspot mutations in the TP53 gene in human cancers? [J].
Evan H Baugh ;
Hua Ke ;
Arnold J Levine ;
Richard A Bonneau ;
Chang S Chan .
Cell Death & Differentiation, 2018, 25 :154-160
[40]   DETECTION OF TP53 GENE-MUTATIONS IN HUMAN SARCOMAS [J].
CASTRESANA, JS ;
RUBIO, MP ;
GOMEZ, L ;
KREICBERGS, A ;
ZETTERBERG, A ;
BARRIOS, C .
EUROPEAN JOURNAL OF CANCER, 1995, 31A (05) :735-738